Electrospun Poly-ε-caprolactone/Poly- l -lysine (PCL/PLL) Nanofibers as an Emergent Material for the Preparation of Electrochemical Immunosensor to Detect Serum Amyloid A

Fatma Ozturk Kirbay,Dilek Odaci

DOI: https://doi.org/10.1021/acsapm.3c03002

2024-03-20

ACS Applied Polymer Materials

Abstract:Serum amyloid (SAA), one of the acute-phase reactants, plays a significant role in acute and chronic inflammatory diseases. It is widely used in the clinical field as a biomarker of inflammation. Developing rapid and sensitive measurement systems is crucial to precisely detect the presence of SAA, even at very low levels. Therefore, in this study, we developed an electrochemical immunosensor using electrospun nanofibers (ESNFs) based on poly-ε-caprolactone (PCL) and poly-l-Lysine (PLL) as an immobilization matrix. ESNFs covered the surfaces of screen-printed carbon electrodes (SPCEs) for enhanced performance. The PCL/PLL ESNFs were characterized using water contact angle measurements, scanning electron microscopy (SEM), Brunauer–Emmett–Teller (BET) method, X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared (FTIR) spectroscopy techniques. Cyclic voltammetry (CV), differential pulse voltammetry (DPV), and impedance spectroscopy (EIS) were employed to characterize the electrochemical behavior of the developed electrode surface. In conjunction with the analytical characterizations of the proposed immunosensor, linear range, limit of detection (LOD), interfering effect of some potential chemicals, and real sample applications were carried out. The sensor exhibited a working range and the linear range of 0.1–50 and 0.1–10 ng/mL with a calculated LOD of 0.061 ng/mL for SAA, respectively. Additionally, the sensor demonstrated advanced specificity, showing no response to the interfering species such as urea, glucose, insulin, and C-reactive protein. Validation of the sensor yielded excellent recovery for the artificial serum (100.04%), human real serum (103.32%), and artificial saliva (99.5%) samples containing 1 ng/mL SAA. Therefore, we believe that the sensor, with its high specificity, and sensitivity, can effectively contribute to the detection of SAA at low levels in biological fluids during clinical tests.

polymer science,materials science, multidisciplinary

What problem does this paper attempt to address?

The main objective of this paper is to develop an electrochemical immunosensor for the detection of serum amyloid A (SAA). SAA is an acute-phase reactant that plays a significant role in both acute and chronic inflammatory diseases and is widely used as a biomarker for inflammation. To accurately detect SAA, especially at low concentration levels, the research team developed an immunosensor based on electrospun nanofibers (ESNFs). These nanofibers are composed of polycaprolactone (PCL) and poly-L-lysine (PLL) and serve as a matrix material for antibody immobilization.

Specifically, the researchers coated PCL/PLL ESNFs on the surface of screen-printed carbon electrodes (SPCEs) to enhance their performance. The nanofibers were thoroughly analyzed using various characterization techniques such as contact angle measurement, scanning electron microscopy (SEM), BET method, X-ray photoelectron spectroscopy (XPS), and Fourier-transform infrared spectroscopy (FTIR). Additionally, the electrochemical behavior of the developed electrode surface was characterized using cyclic voltammetry (CV), differential pulse voltammetry (DPV), and impedance spectroscopy (EIS).

Experimental results indicate that the sensor has a good working range (0.1 to 50 ng/mL), a linear range (0.1 to 10 ng/mL), a limit of detection (LOD) of 0.061 ng/mL, and exhibits high specificity against interfering substances such as urea, glucose, insulin, and C-reactive protein. Furthermore, the sensor performed well in detecting SAA in artificial serum, real human serum, and artificial saliva samples, showing high recovery rates (100.04% to 103.32%). Therefore, the sensor demonstrates high sensitivity and specificity, making it effective for detecting SAA in biological fluids in clinical tests.